Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype

Gut

Volumn 52, Issue 4, 2003, Pages 552-557

  Louis, E ^a   Michel, V ^a   Hugot, J P ^b   Reenaers, C ^a   Fontaine, F ^c   Delforge, M ^c   El Yafi, F ^a   Colombel, J F ^d   Belaiche, J ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b FONDATION JEAN DAUSSET CEPH   (France)

^c Clinique Saint Joseph   (Belgium)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID;

ADULT; ARTICLE; CARD15 GENE; CLINICAL FEATURE; COLON; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; GENE; GENOTYPE; HUMAN; ILEUM; MAJOR CLINICAL STUDY; MALE; NOD2 GENE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SMOKING;

ADULT; AGE OF ONSET; CARRIER PROTEINS; CROHN DISEASE; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NOD2 SIGNALING ADAPTOR PROTEIN; PHENOTYPE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 0037379422     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.4.552     Document Type: Article

References (40)

1. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205.
2. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989;24:2-6.
3. Gower-Rousseau C, Salomez JL, Dupas JL, et al. Incidence of inflammatory bowel disease in Northern France (1988-1990). Gut 1994;35:1433-8.
4. Jenkins D, Balsitis M, Gallivan S, et al. Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol 1997;50:93-105.
5. Sutherland LR. Different patterns of Crohn's disease. In: Prantera C, Korelitz B, eds. Crohn's Disease. New York: Marcel Dekker Inc, 1996:201-15.
6. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucin-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
7. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
8. Hampe J, Cuthbert A, Crouche PJP, et al. Association between insertion mutation in NOD2 gene ond Crohn's disease in German and British population. Lancet 2001;357:1925-8.
9. Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis ond genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70:845-57.
10. Ahmad T, Armuzzi A, Bunce M, et al. The molecular classification of the manifestations of Crohn's disease. Gastroenterology 2002;122:854-66.
11. Cuthbert AP, Fisher SA, Mirza MM, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002;122:867-74.
12. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the working party of the world congresses of gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000;6:8-15.
13. Louis E, Hugot JP, Colombel JF, et al. NOD2/CARD15 mutations in Crohn's disease are associated with young age at diagnosis and ileal location. Gastroenterology 2002;122(suppl):M1405.
14. Eri RD, Pandeya N, Purdie D, et al. Frequency and association of the 3020INSC insertion in the NOD2 Crohn disease susceptibility gene in a well-characterized patient cohort. Gastroenterology 2002;122(suppl):M1410.
15. Vermeire S, Esters N, Pierik M, et al. Detailed study on phenotypical associations of NOD2/CARD15 mutations in Crohn's disease. Gastroenterology 2002;122(suppl):M1413.
16. Louis E, Collard A, Oger AF, et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001;49:777-82.
17. Abreu MT, Taylor KD, Lin YC, et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 2002;123:679-88.
18. Radlmayr M, Török HP, Martin K, et al. The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology 2002;122:2091-2.
19. Hampe J, Grebe J, Nikolaus S, et al. Association of NOD2 (CARD15) genotype with clinical course of Crohn's disease cohort study. Lancet 2002;359:1661-5.
20. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989;34:1841-54.
21. Sutherland LR, Ramcharan S, Bryant H, et al. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990;98:1123-8.
22. Cosnes J, Carbonnel F, Beaugerie L, et al. Effects of smoking on the long term course of Crohn's disease. Gastroenterology 1996;110:424-31.
23. Main J, McKenzie H, Yeaman GR, et al. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. BMJ 1988;297:1105-6.
24. Sendid B, Colombel JF, Jacquinot PM, et al. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol 1996;3:219-26.
25. Quinton JF, Sendid B, Reumaux D, et al. Anti-Sacchoromyces cerevisiae mannan antibodies combined with anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998;42:788-91.
26. Vasiliauskas EA, Kam LY, Karp LC, et al. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 2000;47:487-96.
27. Greenstein AJ, Lachman P, Sachar DB, et al. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut 1988;29:588-92.
28. Sachar DB, Andrews HA, Farmer RG, et al. Proposed classification of patient subgroups in Crohn's disease. Gastroenterol Int 1992;5:141-54.
29. Greenway SE, Buckmire MA, Marroquin C, et al. Clinical subtypes of Crohn's disease according to surgical outcome. J Gastrointest Surg 1999;3:145-51.
30. Steinhart AH, Girgrah N, McLeod RS. Reliability of a Crohn's disease clinical classification scheme based on disease behavior. Inflamm Bowel Dis 1998;4:228-34.
31. Achkar JP, Brzezinski A. Interobserver agreement for disease behaviour phenotype in Crohn's disease. Gastroenterology 2002;122(suppl):W1293.
32. Lautenbach E, Berlin JA, Lichtenstein GR. Risk factors for early postoperative recurrence of Crohn's disease. Gastroenterology 1998;115:259-67.
33. Yamamoto T, Allan RN, Keighley MR. Perforating ileocaecal Crohn's disease does not carry a high risk of recurrence but usually re-presents as perforating disease. Dis Colon Rectum 1999;42:519-24.
34. Peeters M, Nevens H, Baert F, et al. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 1996;111:597-603.
35. Bayless TM, Tokayer AZ, Polito JM II, et al. Crohn's disease: concordance for site and clinical type in affected family-members-potential hereditary influences. Gastroenterology 1996;111:573-9.
36. Satsangi J, Grootscholten C, Holt H, et al. Clinical patterns of familial inflammatory bowel disease. Gut 1996;38:738-41.
37. Farmer RG, Hawk WA, Turnbull RB Jr. Indications for surgery in Crohn's disease. Gastroenterology 1976;71:245-50.
38. Van Kruiningen HJ, Ganley LM, Freda BJ. The role of Peyer's patches in the age- related incidence of Crohn's disease. J Clin Gastroenterol 1997;24:470-5.
39. Kelly JK, Preshaw RM. Origin of fistulas in Crohn's disease. J Clin Gastroenterol 1989;11:193-6.
40. Colombel JF, Grandbastien B, Gower-Rousseau C, et al. Clinical characteristics of Crohn's disease in 72 families. Gastroenterology 1996;111:604-7.